Development of a small animal model to simulate clinical stereotactic body radiotherapy-induced central and peripheral lung injuries by 諛뺢킅�슦 et al.
Development of a small animal model to simulate clinical stereotactic body
radiotherapy-induced central and peripheral lung injuries
Zhen-Yu HONG1, Sung Ho EUN1, Kwangwoo PARK1, Won Hoon CHOI1, Jung Il LEE1,
Eun-Jung LEE1, Ji Min LEE1, Michael D. STORY2 and Jaeho CHO1,*
1Department of Radiation Oncology, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul,
120-752, South Korea
2Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, Texas, USA
*Corresponding author. Department of Radiation Oncology, Severance Hospital, Yonsei University College of Medicine, 50
Yonsei-ro, Seodaemun-gu, Seoul, 120-752, South Korea. Tel: +82-2-2228-8095; Fax: +82-2-312-9033; Email: jjhmd@yuhs.ac
(Received 10 September 2013; revised 27 December 2013; accepted 31 December 2013)
Given the tremendous potential of stereotactic body radiotherapy (SBRT), investigations of the underlying
radiobiology associated with SBRT-induced normal tissue injury are of paramount importance. This study
was designed to develop an animal model that simulates centrally and peripherally located clinical SBRT-
induced lung injuries. A 90-Gy irradiation dose was focally delivered to the central and peripheral areas of the
left mouse lung with an image-guided small-animal irradiation system. At 1, 2 and 4 weeks after irradiation,
micro-computed tomography (micro-CT) images of the lung were taken. Lung function measurements were
performed with the Flexivent® system (SCIREQ©, Montreal, Canada). For the histopathological analysis, the
lungs were fixed by perfusing with formalin, and paraffin sections were stained with hematoxylin and eosin
and Masson’s Trichrome. Gross inspection clearly indicated local lung injury confined to the central and per-
ipheral areas of the left lung. Typical histopathological alterations corresponding to clinical manifestations
were observed. The micro-CT analysis results appeared to correlate with the histopathological findings. Mouse
lung tissue damping increased dramatically at central settings, compared with that at the control or peripheral
settings. An animal model to simulate clinical SBRT-induced central and peripheral lung injuries was devel-
oped and validated with histopathological, radiological and functional analyses. This model increases our
understanding of SBRT-induced central and peripheral lung injuries and will help to improve radiation
therapy in the future.
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INTRODUCTION
For patients with medically inoperable, early-stage non-
small-cell lung cancer (NSCLC), stereotactic body radiother-
apy (SBRT) has emerged as a promising surrogate to con-
ventional fractionated radiotherapy [1, 2]. This extreme
hypofractionation, however, is a significant break from prior
radiobiological understandings and experiences of tissue
toxicity.
Radiation pneumonitis and fibrosis can arise in the lung
after the irradiation of malignant thoracic disease. These
complications can range from relatively mild to life threaten-
ing, depending on a number of factors, including the total ra-
diation dose, fractionation schedule, lung irradiation volume,
and irradiated area location [3]. There is little existing experi-
ence with SBRT for central lung tumors because these
tumors are relatively rare. In addition, common SBRT
dosing schedules, such as three fractions of 20 Gy, are not
safe because of the proximity of the trachea, main stem bron-
chus, esophagus, and heart. Serious complications have been
reported, including death consequent to bacterial pneumonia,
pericardial effusion, radiation pneumonitis, or massive hem-
optysis [4, 5]. By increasing the number of fractions and
reducing the fractional doses, some groups have reported the
successful treatment of central lung tumors with minimal
complications [6]. However, others have reported Grade 5
toxicity related to stereotactic radiotherapy treatment
[4, 7–9]. Guidelines related to lung SBRT toxicity are based
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on extremely limited clinical data, and most have not been
validated. Under these circumstances, an animal model that
simulates clinical SBRT-induced central and peripheral lung
injuries could be helpful in the provision of valuable guide-
lines for clinical and molecular biological studies.
In a previous study [10], we established an experimental
model and image-guided animal irradiation system to study
high dose-per-fraction irradiation such as SBRT at volumes
analogous to those used in human beings. Furthermore, we
found that ablative irradiation could induce obvious fibrosis
at 8 weeks after irradiation, which is usually considered a
late effect. Because we examined pathological changes at
only one timepoint in that study, we do not know what hap-
pened at the earlier timepoints. Moreover, the location effects
on lung pathology and function were not investigated.
In this study, by taking advantage of this image-guided
animal irradiation system, we investigated ablative-dose
focal irradiation-induced lung injuries at two different loca-
tions to simulate SBRT-induced central and peripheral lung
injuries at several earlier timepoints. The ultimate goal of
this study was to develop an understanding of the central
radiobiological parameters of the biological foundation of
the potent hypofractionation used in stereotactic radiosurgery
(SRS) and SBRT so that these therapies can be optimized
for greater tumor control and limited adverse normal tissue
responses.
MATERIALS ANDMETHODS
Irradiation system
Radiation was delivered with an X-RAD 320 (Precision,
North Branford, CT, USA), equipped with a collimator system
composed of 5-cm-thick copper to produce focal radiation
beams. The image-guided device comprised a motorized, 2D
moving stage for accurate positioning, a fluorescent screen
(Kodak Min-R 2000; Carestream Health Inc., Rochester, NY,
USA), and a charge-coupled device (CCD) camera (650D;
Canon Inc., Tokyo, Japan) controlled by a mobile computer
(Fig. 1A and B). The collimators generate a cone beam that
ranges from 1–7 mm in diameter. The percentage depth doses
(PDDs) were measured with GAFCHROMIC EBT2 film, as
shown in Fig. 2. The aluminum filtered X-ray beam dose rate
Fig. 1. Establishment of an image-guided focal irradiation system. (A) An image-guided focal irradiation system was established at Yonsei
University. (B) Schematic diagram of the irradiation system. (C) Image-guided localization to the central and peripheral fields of the mouse
left lung. A 90-Gy dose was given to the mouse left lung in a single fraction. A 3-mm collimator was used to produce focal irradiation
beams. (D) Sharp and steep dose distributions of each collimator at a 1-cm depth, from which the full width half maximum (FWHM) was
determined to fit the mouse irradiation size.
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was 19.7 cGy/s, measured at 320 kV and 12.5 mA by using a
cylindrical ionization chamber within a solid water phantom
(PTW, RW3) at a 2-cm depth and a 17-cm source-to-surface
distance (SSD). The output was calibrated as recommended
by the American Association of Physicists in Medicine TG-61
report [11]. Furthermore, the dose distribution at a depth of
1 cm was considered for the proper collimator size. Figure 1D
shows the sharp and steep dose distributions of each collima-
tor, from which we could determine the full width half
maximum (FWHM) to fit the mouse irradiation size.
Mouse irradiation
All studies involving mice were approved by the Yonsei
University Medical School Animal Care and Use
Committee. Five adult (10-week-old) male C57BL/6 mice
were housed per cage and were allowed to acclimate for
1 week after shipping before treatment. To mimic SBRT con-
ditions by irradiating only a small volume, we selected a
3-mm collimator to administer a 90-Gy dose to the left lung.
Image guidance was used to administer the 3-mm diameter
irradiation field to the left main bronchus, which served as
the counterpart of the clinical central area. The peripheral
setting was located as far as possible from the central setting
to serve as the counterpart of the clinical peripheral area
(Fig. 1C). During irradiation, the mice were anesthetized
with an intraperitoneally administered mixture of 30 mg/kg
of zoletil and 10 mg/kg of rompun. The four legs of the mice
were additionally fixed with adhesive tape. At 1, 2 and
4 weeks after irradiation, the mice were sacrificed. Three
mice were allocated per group, and the experiment was
repeated twice.
Fixation
On the appropriate day after irradiation, the mice were
anesthetized. The lungs were slowly inflated via tracheal
perfusion with phosphate buffered 4% formalin, using an
18-gauge needle attached to a syringe. The lungs were
immersed in fixation solution for several days until they were
completely fixed, after which they were photographed on a
black background.
Histopathology and immunohistochemistry
To visualize histopathological damage in sham-irradiated
and irradiated tissues at each predetermined timepoint, hema-
toxylin and eosin (H&E) and Masson’s Trichrome staining
were performed as previously described [10]. Alveolar in-
flammation was scored as previously described [12] on a
scale of 0–5, with 0 indicating no alveolar inflammation and
5 indicating complete tissue consolidation. Semi-quantitative
assessments of the degree of interstitial fibrosis were assessed
by using a predetermined numerical scale of 0–8, based on
the Ashcroft scoring method [13]. The criteria for this scoring
were based on histological features such as the alveolar wall
thickness, fibrotic damage to the lung structures, and fibrous
lesions.
Lung functional assessment
Lung function in irradiated mice was evaluated with the
Flexivent system (Flexivent®; SCIREQ©, Montreal, QC,
Canada), which measures flow–volume relationships in the
respiratory system. This system uses forced oscillation to dis-
criminate between airway and lung tissue variables. The
associated protocols adhered to the manufacturer’s instruc-
tions. Briefly, after anesthetization, mice were connected to a
computer-controlled small-animal ventilator and quasi-
sinusoidally ventilated with a tidal volume of 10 ml/kg at a
frequency of 150 breaths/minute. As spontaneous breathing
should be avoided with this technique, mouse breathing was
stabilized with an automatic ventilator until the interruption
wave disappeared. All perturbations were performed sequen-
tially until three acceptable measurements (coefficient of
determination [COD] > 0.95) were recorded for each subject,
from which an average was calculated. The lung tissue vari-
ables of inspiratory capacity, tissue damping, and hysteresis
were measured.
Computed tomography scanning
Computed tomography (CT) images were collected on a volu-
metric CT scanner (NFR-Polaris-G90MVC; NanoFocusRay,
Iksan, Korea) at 50 kVp, 180 µA and 150 mGy. Images were
acquired at 142 ms per frame and 700 views and were recon-
structed by using the volumetric cone-beam reconstruction
(FDK) in-line/off line mode. The reconstructed image was
1232 × 1120 pixels and contained 512 slices. To generate 3D
images, the final reconstructed data were converted to the
Digital Imaging and Communications in Medicine (DICOM)
format by 3D-rendering software (Lucion; MeviSYS, Seoul,
Korea). Voxels thresholds of −700 and −350 Hounsfield
units (HU) were required to obtain reasonable 3D images
Fig. 2. Depth–dose relationships with different collimator sizes.
The collimators generated a cone beam that ranged from 1–7 mm in
diameter. The percentage depth doses (PDDs) were measured with
GAFCHROMIC EBT2 film.
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that defined the lung surface. Volumetric analysis was
performed from 3D lung images created through isosurface
profiling. Lung parenchyma density measurements were
obtained from the average HU within a circle (3.0-mm diam-
eter) in the irradiated field that avoided both the high-density
large blood vessels and motion artifacts at the lung boundary.
Statistics
Data were statistically analyzed with the Student’s t-test, and
differences with a P-value <0.05 were considered significant.
RESULTS
Gross morphology
We observed gross lung morphology at each timepoint after
focally delivering doses of 90 Gy to the central and periph-
eral areas of the mouse left lung (Fig. 3A). At 1 week after
irradiation, we did not observe morphological abnormalities
on the central or peripheral lung surfaces, compared with the
control. Two weeks after irradiation, inflammation, charac-
terized by a dark area with a white ring-like boundary,
appeared in the peripheral irradiated area. In the central
Fig. 3. Morphologic observation. (A) Representative gross findings. Mice were sacrificed at the indicated timepoints
after irradiation, 4% buffered paraformaldehyde in phosphate-buffered saline (PBS) was instilled via the trachea, and the
lungs were immersed in fixation solution for several days. Lungs were photographed after complete fixation.
(B) Hematoxylin–eosin-stained lung sections from a minimum of three mice were examined at each timepoint.
Representative images of the major findings are shown. The arrows indicate the injury area (magnification: ×12.5).
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irradiated area, however, we observed a white oval-shaped
injury. Four weeks after irradiation, the healing process was
evident, characterized by tissue contraction, fibrous scar
tissue, and a clear boundary between the injured and normal
tissue. Overall, the gross inspection revealed a clear local
lung injury confined to the central and peripheral areas of the
left lung.
Histopathological damage
Significant abnormalities consequent to focused ablative dose
irradiation were observed in the H&E-stained sections col-
lected at different timepoints (Figs 3B and 4A). The sequential
and pathological alterations observed in the central and periph-
eral locations demonstrated synchronous changes. At 1 week
after irradiation, mild interstitial inflammatory cell infiltration
was observed. Two weeks after irradiation, intra-alveolar
hyaline material was observed. Regarding focal irradiation,
numerous foamy macrophages aggregated in a distal part of
the irradiated area, whereas hemosiderin-laden macrophages
were observed in the center of the irradiated area. Four weeks
after irradiation, the hyaline materials fragmented and disap-
peared to a certain extent, and fibrous exudates were present in
the air spaces along with inflammatory cell infiltration. The al-
veolar inflammation score at 2 weeks post-irradiation was sig-
nificantly higher (4.8 ± 0.16), compared with that in the other
two groups (P < 0.05, Fig. 4B).
To further confirm fibrosis, lung sections were stained
with Masson’s Trichrome to visualize collagen deposition.
Representative micrographs of the stained lung sections are
shown in Fig. 4C. No collagen was detected at 1 week after
Fig. 4. Histopathologic analysis. (A) Hematoxylin–eosin-stained lung sections from a minimum of three mice were examined at each
timepoint. Representative images of the major findings are shown. The arrows indicate the inflammatory cells present at Week 1 and hyaline
material present at Week 2 (magnification: ×400). (B) Alveolar inflammation was scored on a scale of 0–5, with 0 indicating no alveolar
inflammation and 5 indicating complete tissue consolidation (filled stars, P < 0.05 vs any other group). (C) Lung sections were stained with
Masson’s Trichrome stain to visualize collagen deposition. Representative micrographs (magnification: ×400) of stained lung tissue are
shown at each timepoint. (D) Semi-quantitative assessments of the degree of interstitial fibrosis were determined by using a predetermined
numerical scale of 0–8, based on the Ashcroft scoring method (filled stars, P < 0.05 vs any other group).
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irradiation. At 2 weeks after irradiation, small amounts of
collagen were detected in the intra-alveolar and interstitial
areas. At 4 weeks after irradiation, extensive collagen was
observed, correlating with late-stage fibrosis. The lung fibro-
sis score at 4 weeks post-irradiation was significantly higher
(7.16 ± 0.44), compared with that in the other two groups
(P < 0.05, Fig. 4D).
Micro-CT analysis
Micro-CT, which is CT conducted on a microscopic level, is
comparable with clinical CT in human subjects [14].
Micro-CT coronal sections taken through the main bronchus
are shown in Fig. 5A. One week after irradiation, there were
no obvious changes in the central and peripheral irradiated
fields. Two weeks after irradiation, ground-glass opacities
could be observed throughout the left lung in both the central
and peripheral irradiated fields. Four weeks after irradiation,
sharp margin consolidation that was confined to the central
and peripheral irradiated fields was observed. In the central
setting, the administration of 90 Gy of focal irradiation to the
left main bronchus did not obstruct the airway at any time-
point. The 3D images in Fig. 5B provide a more intuitive in-
dication of the airway obliteration than do the 2D coronal
sections and support the similar findings. The lung densities
in the irradiated areas were evaluated as averaged Hounsfield
units. As shown in Fig. 5C, the lung densities in both the
central and peripheral settings increased significantly at
2 and 4 weeks, compared with the control. The two settings,
however, did not differ significantly from each other. Two
weeks after irradiation, although the CT-measured whole
lung volumes in the central and peripheral settings were sig-
nificantly lower than that of the control, the two settings did
not differ significantly from each other (Fig. 5D). Four
weeks after irradiation, the whole lung volume recovered to
near-control values. Overall, the results of the micro-CT
analysis appeared to correlate with the histopathological
findings.
Functional study of irradiation-induced lung injury
Changes in lung function were evaluated by measuring the
forced-oscillation lung mechanics (Fig. 6). The inspiratory
capacity decreased significantly in mice with peripheral area
irradiation, compared with controls (P < 0.05) at 2 and
4 weeks after irradiation (Fig. 6A). Respiratory system ela-
stance increased significantly in mice with central area irradi-
ation, compared with controls, at 4 weeks after irradiation
(P < 0.05; Fig. 6B). Hysteresis, which reflects pulmonary
recruitability, decreased in both the central and peripheral
areas at 4 weeks after irradiation (Fig. 6C). Tissue damping,
which reflects the energy dissipation in lung tissues, increased
dramatically in the central areas, compared with the control
and peripheral areas, at 4 weeks after irradiation (P < 0.05;
Fig. 6D). Overall, the lung mechanics measured by the
forced-oscillation method in our animal model generally dis-
played signs of respiratory distress at 4 weeks after irradiation,
compared with the mechanics in control mice. Furthermore,
respiratory system elastance and tissue damping are potential
parameters that could be used to distinguish functional differ-
ences between central and peripheral irradiation.
DISCUSSION
This preliminary and exploratory study was designed to
develop an animal model that would simulate clinical
SBRT-induced lung injuries in central and peripheral loca-
tions. A previously established, image-guided animal irradi-
ation system was used to administer ablative doses of focal
irradiation to different lung locations. At several timepoints
after irradiation, pathological, radiological and functional
studies were performed to verify toxicities.
Experiments in a conventional fractionated radiotherapy
(CFRT) mouse model, which utilizes low-dose whole or
half-lung irradiation, generally result in diffuse radiation-
induced lung injuries (RILIs) [15–19]. In our system,
however, RILI was confined to a focal irradiated area.
Not only did the gross findings of our study differ from
those of previous CFRT simulating models, but the histo-
pathological findings also revealed some interesting differ-
ences. Fibrin-rich serum proteins are usually discovered after
radiotherapy, and in some patients these are associated with
hyaline material formation [20, 21].While the typical hyaline
materials characteristic of human acute radiation pneumonitis
do not occur in most other mammals (including rats and
rabbits) [22], they are occasionally observed in a few strains
of mice, including C57BL/6 mice treated with low-dose
irradiation [23]. Consistent with the results of a previous
study, we observed hyaline materials in the irradiated field in
C57BL/6 mice treated with ablative-dose irradiation.
Nonetheless, the emergence time differed from that of the
CFRT mouse model. Some research groups report several
months are required to generate hyaline materials after CFRT
with an irradiation dose range of 2–32 Gy [24–27]. In our
study, the hyaline materials appeared at only 2 weeks after
irradiation. The emergence time of the hyaline membrane
seems to be related to the radiation dose. Regarding fibrosis,
it is clear that the response to 5 Gy was negligible, and after
10 Gy, the initial increase in collagen was not progressive
during the 9-month experimental period [28]. In contrast,
overt fibrosis was observed only at 4 weeks after irradiation
in our system. One of the most striking findings was that ex-
tensive inflammatory cell infiltration and a slight collagen
deposition were simultaneously observed, suggesting an
overlap of pneumonitis and the fibrotic phase. CFRT is well
known to induce dissociation between the two distinct types
of lung damage, pneumonitis and fibrosis, which occur at 3–
6 months and 6 months after radiation, respectively, in both
animals and humans [29, 30].
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Because gross morphology was evaluated after inflating
the mouse lungs with a fixative solution, we were not able to
investigate in vivo malfunctions, such as obstructions, that
usually occur in injured lungs. These pathologies, however,
can easily be investigated by micro-CT analysis. In the
micro-CT images, we clearly saw a loss of air space during
Fig. 5. Micro-CT analysis. (A) Typical micro-CT images of coronal sections cutting through the main bronchus at the
indicated timepoint are shown. (B) Areas of density between −700 and −350 HU on 3D micro-CT images are shown in pink.
(C) Average HU in the irradiated area (filled stars, P < 0.05 vs control). (D) Volumetric analysis was performed from 3D images
of the lung that were created through isosurface profiling (filled stars, P < 0.05 vs control).
Z.-Y. Hong et al.654
the pneumonitis stage that dramatically recovered during the
late stage of fibrosis (Fig. 5B). Moreover, typical micro-CT
manifestations of SBRT-induced lung injuries, such as
ground glass opacity and consolidation [31], were detected at
2 and 4 weeks after irradiation (Fig. 5A). Volumetric mea-
surements can also be used to monitor the course of disease
(Fig. 5D). Overall, the micro-CT results in our study demon-
strated that this assay could be used to detect and quantify ab-
lative and focally delivered radiation-induced lung injuries.
In addition to the histopathological and micro-CT studies,
the functional dependencies and influences of the organized
tissues must be assessed through meticulous studies of
physiological changes. Recent reports have strongly advo-
cated the re-evaluation of traditional histological and bio-
chemical tools with which to quantify pulmonary injuries, as
human trials of pulmonary fibrosis mostly use lung function
parameters [32, 33]. Hysteresis is an important phenomenon
that is readily seen in pressure–volume (P–V) curves; the
larger the hysteresis, the higher the lung recruitability. In
patients with acute respiratory distress syndrome (ARDS),
hysteresis decreased as the positive end-expiratory pressure
(PEEP) increased because less of the lung had collapsed at
the beginning of the P–V curve [34]. In our study, a decrease
in lung hysteresis after 4 weeks can be interpreted to mean
that an ablative dose of focal irradiation significantly reduced
lung collapse, possibly due to the enhanced fibrotic tension.
There have been concerns that patients with central lung
lesions are at an increased risk of high-grade toxicity. The
4-year results of a phase II trial at the University of Indiana
showed that SBRT for lung tumors resulted in an almost
3-fold increase in Grade 3–5 toxicity in patients with central
versus peripheral tumors (27.3% vs 10.4%, P = 0.088) [5].
Although this difference was not statistically significant, the
data have raised concerns among clinicians. In addition,
Song et al. [35] reported on nine patients with central tumors
who were treated with SBRT (40–60 Gy in three or four
fractions), three (33%) of whom developed Grade 3–5
pulmonary toxicity. In our functional study, the respiratory
system elastance and tissue damping results suggest a mech-
anical difference between central and peripheral settings.
Tissue damping is closely related to tissue elastance and
reflects energy dissipation in the lung tissue. Although the
ablative focally delivered radiation cannot induce stenosis in
the main bronchus, which is visible by micro-CT, it affects
the respiratory mechanical energy dissipation to a certain
extent. Tissue damping or energy dissipation is closely
related to tissue resistance and reflects either changes in the
physical properties of the tissue or heterogeneity in the
regional airways [36]. Fibrotic tissue within the central area
would induce traction to the main bronchus, resulting in low
mobility or stiffness of the main bronchus. Moreover, radi-
ation might induce significant damage to the visco-elastic
features of the main bronchus. These changes in the main
bronchus would induce a significant alteration of the airflow
mechanics through the bronchus to the entire left lung, which
would manifest as significant increases in tissue damping
(energy dissipation) in central settings. Nonetheless, the
existence of fibrosis in the peripheral field only influences a
Fig. 6. Functional evaluation of mouse lung after irradiation. At the indicated timepoints after irradiation, functional measurements of the
mouse lung were collected with a flexivent system. (A) Inspiratory capacity (filled stars, P < 0.05 vs control), (B) respiratory system
elastance (filled star, P < 0.05 vs control), (C) hysteresis (filled stars, P < 0.05 vs control), and (D) tissue damping (filled star, P < 0.05,
central vs control and peripheral).
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local limited area of the lung volume, which might explain
why minor alterations in tissue damping were detected.
Hence, lung functional measurements might serve as a valu-
able adjunct with which to distinguish between central and
peripheral pulmonary injuries. Based on our results, mechan-
ical lung function measurements at later timepoints, when
fibrotic remodeling has had sufficient time to develop, are
sensitive and reliable surrogates of lung injuries at different
locations after ablative dose focal irradiation. On one hand,
these parameters reflect whole-lung visco-elastic behavior
and could serve as novel endpoints of lung fibrosis. On the
other hand, a functional experiment that compares focal RILI
consequent to the delivery of an ablative dose with large
RILI consequent to the delivery of a conventional fractio-
nated low dose in this model is needed in future studies.
One of the limitations of our study is that we investigated
the RILI in normal, tumor-free tissues. In a tumor environ-
ment, direct interactions between the tumor cells and normal
cells, or indirect interactions mediated by the cytokines
secreted by these cells, might influence the RILI to some
extent. Although these factors were ignored, we believe that
our findings remain significant with regard to evaluations of
RILI in normal tissue caused by focally delivered ablative
radiation.
An animal model that simulates clinical SBRT-induced
lung injuries in the central and peripheral lung was devel-
oped and validated with histopathological, radiological and
functional analyses. This model increases our understanding
of SBRT-induced central and peripheral lung injuries and
could help to improve radiation therapy in the future.
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